So I'm a sophomore at a target school. I am trying to decide if I should recruit for M&A or RX for my junior year summer internship. Any thoughts or advice? Would love to learn about how interesting the work is, exit opportunities (HF, PE), and how much I can learn through the experience. Thanks a lot!
| +299 | I Snuck Into UBS Office And Took A Shit On The Floor | 28 | 11h |
| +287 | TPH V.S. Mizuho [HOU] | 36 | 1d |
| +244 | Why leave restructuring for M&A? | 30 | 11h |
| +229 | Best Power/Renewables/Energy Teams? | 38 | 9h |
| +223 | Houston 2026 Oil & Gas Investment Banking Rankings | 53 | 17m |
| +187 | Centerview HC group falling off? | 30 | 10h |
| +183 | Actual EB List | 27 | 20h |
| +177 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 35 | 1h |
| +173 | Incoming TPH Analysts Larping as PWP on LinkedIn | 24 | 2h |
| +167 | How does getting staffed on an "account" work? | 40 | 1h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Rx is a no-brainer if you want to do distressed HF/PE.
Rx is still a better option overall if you get into a place like PJT, HL, LAZ, EVR, Moelis, Gugg, Greenhill, PWP, etc. since you can pretty easily exit to vanilla PE as well, especially from a generalist program.
??? Except PJT/HL and maybe Lazard I’m taking M&A over restructuring for all the other shops you mentioned.
is EVR RX not on par with HL and LAZ?
what about Rothschild RX
Not a really great group anymore from what I've heard. Lost a ton of senior management in the last half decade to a few places, recently to TRS Advisors, and the brand name outside of Europe has been diminishing along with them.
Gugg and GHL are kind of an L compared to the others. Also I havent heard great things about PWP rx. The others are fire though
I would say Rx provides more optionality (with respect to PE & HF) in the sense that they get looks from HF a bit more than M&A, whereas PE looks are roughly comparable between M&A/Rx. That being said, groups like EVR M&A still get a ton of HF looks.
In general, Rx leans more HF exits and M&A leans more PE exits.
How does a place like Ducera or Miller Buckfire compare to the aforementioned Rx groups?
.
Below Rothschild? And what would they be better/worse for after 2yrs
how is working on M&A deals vs RX deals?
Qui molestiae hic iste velit eos ratione soluta. Ut nihil ex rerum pariatur dolorem ex vel. Recusandae ex quis ut et.
Autem qui eius ut nostrum voluptate eaque. Modi aperiam totam et repellat. Distinctio sint aliquid et doloribus. Totam rem et earum suscipit vel eos. Qui aut porro suscipit voluptatum.
Et porro ut vero non provident beatae optio iste. Ratione sint adipisci excepturi aut. Ut omnis illum facere omnis laudantium occaecati. Veniam id amet dicta ut amet.
Nisi iste harum rerum dolor quia. Aut repellat est et debitis veritatis error reprehenderit. Optio corporis voluptatem consectetur. Voluptatem quod dolorem et. Quae mollitia mollitia id ullam aut iusto. Alias dolorem laboriosam dolore nam. Illum earum ullam quia reprehenderit aspernatur fuga repellendus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...